Olaparib in combination with pegylated liposomal doxorubicin for platinum-resistant ovarian cancer regardless of BRCA status: a GEICO phase II trial (ROLANDO study)
| Autor: | Perez-Fidalgo, J.A., Cortés, A., Guerra, E., García, Y., Iglesias, M., Bohn Sarmiento, U., Calvo García, E., Manso Sánchez, L., Santaballa, A., Oaknin, A., Redondo, A., Rubio, M.J., González-Martín, A. |
|---|---|
| Zdroj: | In ESMO Open August 2021 6(4) |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|